Journals / Archives of Rheumatology / 2021 / Cilt: 36 - Sayı: 3

The evaluation of nailfold capillaroscopy pattern inpatients with fibromyalgia

Pages
341–348
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Of the capillaroscopic parameters, the mean capillary loop diameter, number of micro-aneurysms, avascular areas, and neoangiogeniccapillaries were significantly higher in the patient group compared to the controls (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to evaluate nailfold capillaroscopic pattern in patents with fibromyalgia and to assess the relation of capillaroscopicparameters with clinical variables and disease-related measures.
📊
Key Findings & Data:Patients and methods: This cross-sectional, case-control study included 60 participants (4 males, 56 females; mean age: 44.0±8.2 years;range, 26 to 64 years) between August 2019 and November 2019.
💡
Conclusion & Impact:Results: Of the capillaroscopic parameters, the mean capillary loop diameter, number of micro-aneurysms, avascular areas, and neoangiogeniccapillaries were significantly higher in the patient group compared to the controls (p
🔬Design:Survey & Empirical Study
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aims to evaluate nailfold capillaroscopic pattern in patents with fibromyalgia and to assess the relation of capillaroscopicparameters with clinical variables and disease-related measures. Patients and methods: This cross-sectional, case-control study included 60 participants (4 males, 56 females; mean age: 44.0±8.2 years;range, 26 to 64 years) between August 2019 and November 2019. All participants were divided into two groups as the primary fibromyalgiagroup (n=30) who met the 2016 modified American College of Rheumatology Diagnostic Criteria for Fibromyalgia and the control group (n=30)consisting of age- and sex-matched healthy individuals. Nailfold capillaroscopy was performed by a digital microscope under a magnificationof 200¥. Capillary density, capillary loop diameter, number of dilated, giant and neoangiogenic capillaries, capillary shape, number of avascularareas, micro-aneurysms and micro-hemorrhages were evaluated by an assessor who was blind to the group allocation. In the fibromyalgia group,Widespread Pain Index, Symptom Severity Scale scores, and Fibromyalgia Severity scores were calculated. Health status and presence of benignjoint hypermobility syndrome (BJHS) were evaluated using the Fibromyalgia Impact Questionnaire (FIQ) and revised Brighton criteria, respectively. Results: Of the capillaroscopic parameters, the mean capillary loop diameter, number of micro-aneurysms, avascular areas, and neoangiogeniccapillaries were significantly higher in the patient group compared to the controls (p

🔖

Cite This Article

SARIYILDIZ, A., BENLİDAYI, İ. Ç., ERDOĞAN, E. K. (2022). The evaluation of nailfold capillaroscopy pattern inpatients with fibromyalgia. Archives of Rheumatology, Cilt: 36 - Sayı: 3, 341–348. https://ajindex.com/articles/448013

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 2010;39:448-53
  2. Lage-Hansen PR, Chrysidis S, Lage-Hansen M, Hougaard A, Ejstrup L, Amris K. Concomitant fibromyalgia in rheumatoid arthritis is associated with the more frequent use of biological therapy: a cross-sectional study. Scand J Rheumatol 2016;45:45-8
  3. Macfarlane GJ, Pathan E, Siebert S, Packham J, Gaffney K, Choy E, et al. AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS). BMC Rheumatol 2019;3:19
  4. Coskun Benlidayi I. Fibromyalgia interferes with disease activity and biological therapy response in inflammatory rheumatic diseases. Rheumatol Int 2020;40:849-58
  5. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 2016;46:319-29
  6. Morf S, Amann-Vesti B, Forster A, Franzeck UK, Koppensteiner R, Uebelhart D, et al. Microcirculation abnormalities in patients with fibromyalgia - measured by capillary microscopy and laser fluxmetry. Arthritis Res Ther 2005;7:R209-16
  7. Katz DL, Greene L, Ali A, Faridi Z. The pain of fibromyalgia syndrome is due to muscle hypoperfusion induced by regional vasomotor dysregulation. Med Hypotheses 2007;69:517-25
  8. Choi DH, Kim HS. Quantitative analysis of nailfold capillary morphology in patients with fibromyalgia. Korean J Intern Med 2015;30:531-7
  9. Lambova SN, Muller-Ladner U. Capillaroscopic findings in primary fibromyalgia. Curr Rheumatol Rev 2018;14:36-41
  10. Scolnik M, Vasta B, Hart DJ, Shipley JA, McHugh NJ, Pauling JD. Symptoms of Raynaud's phenomenon (RP) in fibromyalgia syndrome are similar to those reported in primary RP despite differences in objective assessment of digital microvascular function and morphology. Rheumatol Int 2016;36:1371-7
  11. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991;18:728-33
  12. Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 2000;20:9-12
  13. Beighton P, Solomon L, Soskolne CL. Articular mobility in an African population. Ann Rheum Dis 1973;32:413-8
  14. Grahame R, Bird HA, Child A. The revised (Brighton 1998) criteria for the diagnosi